Literature DB >> 10641954

Treatment of nocturia in the elderly.

H E Kallas1, J Chintanadilok, J Maruenda, J L Donahue, D T Lowenthal.   

Abstract

The aging process, behavioural habits and a multitude of pathological conditions are the main contributors to the development of nocturia in the elderly. Age-related physiological changes can alter the regular pattern of urine excretion and lead to increased nocturnal frequency of voiding. In addition, aging is associated with anatomical and physiological changes of the urinary tract itself that predispose to increased urinary frequency without affecting urine volume. Several urinary and extra-urinary tract conditions may have nocturia as a prominent symptom. These conditions can be grouped as those associated with bladder overactivity, bladder outlet obstruction, bladder hypotonicity and an increased urine volume. A detailed assessment that gathers clues from the medical history, physical examination and laboratory is of utmost importance in identifying the specific causes. Overactive bladder can be idiopathic or associated with different triggers such as UTI, bladder stones, bladder tumours and CNS diseases that disrupt the normal inhibitory signals to the bladder. It may be cured by the successful elimination of the trigger conditions. Therapeutic modalities include behavioural therapies with scheduled voiding, anticholinergic drugs and in women the use of transvaginal electrical stimulation. Benign prostatic hyperplasia is the most common cause of bladder outlet obstruction in men. Different drug classes (e.g. peripheral alpha-adrenoceptor blockers and 5 alpha-reductase inhibitors) are now available for the treatment of mild to moderate symptoms. Surgery is reserved for patients with severe symptoms or with complications, with new and less invasive surgical techniques being preferred. Bladder hypotonicity is usually caused by peripheral neuropathies, spinal cord lesions and the indiscriminate use of drugs with anticholinergic actions. Treatment involves discontinuation of implicated drugs, short term use of cholinergic drugs and urinary catheterisation. Increased urine volumes and nocturia are frequently seen in hyperosmolar and oedematous states. Excessive ingestion of fluids, caffeinated or alcoholic beverages are habits that commonly produce nocturia. Although more definitive studies are awaited, low dose loop diuretics given a few hours prior to bedtime and desmopressin nasal spray or tablets may be useful alternatives for the control of nocturic symptoms in elderly patients with nocturnal polyuria syndrome. Whenever nocturia is present, clinicians should try to identify its causes by means of a thorough history, physical examination and pertinent complimentary tests. Once the specific cause or causes are found, most cases can be satisfactorily managed with behavioural, pharmacological or surgical therapies.

Entities:  

Mesh:

Year:  1999        PMID: 10641954     DOI: 10.2165/00002512-199915060-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   4.271


  52 in total

1.  DDAVP in the management of nocturia in multiple sclerosis.

Authors:  G Valiquette; G M Abrams; J Herbert
Journal:  Ann Neurol       Date:  1992-05       Impact factor: 10.422

2.  The effect of volume expansion on atrial natriuretic peptide and cyclic guanosine monophosphate levels in young and aged subjects.

Authors:  A C Tan; W H Hoefnagels; L M Swinkels; P W Kloppenborg; T J Benraad
Journal:  J Am Geriatr Soc       Date:  1990-11       Impact factor: 5.562

Review 3.  Bladder training in the management of lower urinary tract dysfunction in women. A review.

Authors:  J A Fantl; J F Wyman; S W Harkins; E C Hadley
Journal:  J Am Geriatr Soc       Date:  1990-03       Impact factor: 5.562

4.  A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo.

Authors:  J M Reynard; A Cannon; Q Yang; P Abrams
Journal:  Br J Urol       Date:  1998-02

5.  High plasma concentrations of human atrial natriuretic polypeptide in aged men.

Authors:  M Ohashi; N Fujio; H Nawata; K Kato; H Ibayashi; K Kangawa; H Matsuo
Journal:  J Clin Endocrinol Metab       Date:  1987-01       Impact factor: 5.958

6.  High prevalence of benign prostatic hypertrophy in the community.

Authors:  W M Garraway; G N Collins; R J Lee
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

7.  Desmopressin for the treatment of nocturnal polyuria in the elderly: a dose titration study.

Authors:  R Asplund; B Sundberg; P Bengtsson
Journal:  Br J Urol       Date:  1998-11

Review 8.  Urinary incontinence in the elderly population.

Authors:  D S Chutka; K C Fleming; M P Evans; J M Evans; K L Andrews
Journal:  Mayo Clin Proc       Date:  1996-01       Impact factor: 7.616

9.  Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease.

Authors:  O Suchowersky; S Furtado; G Rohs
Journal:  Mov Disord       Date:  1995-05       Impact factor: 10.338

10.  Diurnal variation in the levels of antidiuretic hormone in the elderly.

Authors:  R Asplund; H Aberg
Journal:  J Intern Med       Date:  1991-02       Impact factor: 8.989

View more
  5 in total

Review 1.  Desmopressin: in adults with nocturia.

Authors:  Risto S Cvetković; Greg L Plosker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Urinary nitrite excretion and urinary variables in patients with primary nocturnal frequency of micturition: effects of indomethacin suppositories.

Authors:  Noori S Al-Waili; Thia N Al-Waili; Ali N Al-Waili; Khelod Y Saloom
Journal:  World J Urol       Date:  2005-09-27       Impact factor: 4.226

3.  Nocturia and complementary indices: determination and quantification of the cause of nocturia by frequency-volume charts in women with lower urinary tract symptoms.

Authors:  Ja Hyeon Ku; Dae Jung Lim; Seok-Soo Byun; Jae-Seung Paick; Seung-June Oh
Journal:  Urol Res       Date:  2004-01-16

4.  Age related change of nocturia in women.

Authors:  Sun-Ouck Kim; Jun Seok Kim; Hee Sun Kim; Eu Chang Hwang; Kyung Jin Oh; Dongdeuk Kwon; Kwangsung Park; Soo Bang Ryu
Journal:  Int Neurourol J       Date:  2010-12-31       Impact factor: 2.835

5.  Nocturia independently predicts left ventricular hypertrophy and left atrial enlargement among patients with cardiac symptoms.

Authors:  Kuo-Wei Kao; Weiming Cheng; Ching-Ju Wu; Yu-Hua Fan
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.